> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Geriatric Information in Drug Labels
- URL: https://www.fdaweb.com/draft-guide-on-geriatric-information-in-drug-labels/
- Published: 2020-09-16T12:00:00.000Z
- Updated: 2026-09-14T16:28:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147661

*Federal Register* notice: FDA has made available a draft guidance entitled *Geriatric Information in Human Prescription Drug and Biological Product Labeling*. The document provides recommendations to help ensure that appropriate geriatric information is consistently placed in the proper sections and subsections within labeling. It also provides examples of geriatric use statements in labeling and examples of when the labeling regulations authorize FDA to permit applicants to omit or revise specific information otherwise required. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-09-16/pdf/2020-20435.pdf?ref=fdaweb.com).